Show simple item record

Idarucizumab for Dabigatran Reversal-full Cohort Analysis (RE-VERSE AD Study)

dc.contributor.authorEkizoglu, Esme
dc.date.accessioned2021-03-03T11:36:17Z
dc.date.available2021-03-03T11:36:17Z
dc.date.issued2018
dc.identifier.citationEkizoglu E., "Idarucizumab for Dabigatran Reversal-full Cohort Analysis (RE-VERSE AD Study)", TURKISH JOURNAL OF NEUROLOGY, cilt.24, sa.2, ss.199-200, 2018
dc.identifier.othervv_1032021
dc.identifier.otherav_28d0cd86-85e2-4d74-8f12-28131fc93fac
dc.identifier.urihttp://hdl.handle.net/20.500.12627/32290
dc.identifier.urihttps://doi.org/10.4274/tnd.37233
dc.language.isoeng
dc.subjectNöroloji
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectKLİNİK NEUROLOJİ
dc.titleIdarucizumab for Dabigatran Reversal-full Cohort Analysis (RE-VERSE AD Study)
dc.typeMakale
dc.relation.journalTURKISH JOURNAL OF NEUROLOGY
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.identifier.volume24
dc.identifier.issue2
dc.identifier.startpage199
dc.identifier.endpage200
dc.contributor.firstauthorID248772


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record